Signet Healthcare Partners - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
1998
Signet Healthcare Partners specializes in providing growth capital to innovative healthcare companies globally. The firm focuses on commercial-stage companies in the pharmaceutical and medical devices sectors that are generating revenue or preparing for commercial launch. Signet typically invests in Series B and later stages, with investments ranging from $16 million to $93 million.
As an active investor, Signet partners closely with management teams to support growth and build successful businesses. Their portfolio includes notable companies such as Bionpharma, KEW Group, Leading Pharma, and Paragonix Technologies. With a strong reputation built over years of experience, Signet Healthcare Partners offers valuable expertise and support to help companies navigate the complex healthcare industry.
Signet Healthcare Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies8
Current Portfolio Count8
Top Investment Stages
Series B3 (60.0%)
Series C1 (20.0%)
Series D1 (20.0%)
Stage Mix
Series B 60%Series C 20%Series D 20%
Concentration shown as share of disclosed investments by stage.